| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| ADS | Alliance Data Systems Corporation | $246.12 | $13.52B | Downtrend |
The Latest: US wants drugmakers to put prices in TV ads
http://www.startribune.com/business/497622191.html
Oct 15, 2018 - The Latest on drugmakers disclosing list prices of advertised drugs (all times local):
0
Drug Companies To Disclose Pricing Information In Ads
http://feeds.benzinga.com/~r/benzinga/~3/HNVCGNBXgUA/drug-companies-to-disclose-pricing-information-in-ads
Oct 15, 2018 -
When anger over EpiPen pricing erupted in 2016, generic drugmaker Mylan NV (NASDAQ: MYL) was villainized.
The price of the autoinjector used for severe allergic reactions was hiked by about 500 percent between 2007 and 2016.
0
NutriSystem's New Ads Have Improved But Are Still Out Of Touch, Analyst Says
http://feeds.benzinga.com/~r/benzinga/~3/_ogMbKREqXE/nutrisystems-new-ads-have-improved-but-are-still-out-of
Oct 15, 2018 -
Nutrisystem Inc. (NASDAQ: NTRI) shares plummeted Monday after receiving a downgrade.
The Analyst
D.A. Davidson analyst Linda Bolton Weiser downgraded the stock from Neutral to Underperform and lowered her price target from $40 to $28.
0
Should You Buy Alliance Data Systems (ADS) Ahead of Earnings?
http://www.zacks.com/stock/news/327961/should-you-buy-alliance-data-systems-ads-ahead-of-earnings?cid=CS-ZC-FT-327961
Oct 15, 2018 - Alliance Data Systems (ADS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
0
AcelRx Pharma up 29% premarket on positive Ad Com vote for Dsuvia
https://seekingalpha.com/news/3397185-acelrx-pharma-29-percent-premarket-positive-ad-com-vote-dsuvia?source=feed_news_all
Oct 15, 2018 - AcelRx Pharmaceuticals (NASDAQ:ACRX) is up 29% premarket light volume following a thumbs up by an FDA advisory committee on pain med DSUVIA (sufentanil sublingual tablet).Previously: FDA Ad
0
Can Alliance Data (ADS) Deliver Q3 Earnings Beat on the Trot?
http://www.zacks.com/stock/news/328071/can-alliance-data-ads-deliver-q3-earnings-beat-on-the-trot?cid=CS-ZC-FT-328071
Oct 15, 2018 - Alliance Data's (ADS) segmental strength is likely to aid third-quarter results.
0
TV ads draw fire in hard-fought Twin Cities congressional races
http://www.startribune.com/business/497289261.html
Oct 12, 2018 - Accuracy of allegations called into question.
0
Avenue Therapeutics up 95% on dim Ad Com prospects for Trevena's oliceridine
https://seekingalpha.com/news/3396816-avenue-therapeutics-95-percent-dim-ad-com-prospects-trevenas-oliceridine?source=feed_news_all
Oct 11, 2018 - Thinly traded nano cap Avenue Therapeutics (ATXI +95.2%) is the latest tiny biotech to break out. Shares are up on a whopping 66x surge in volume as they try to break free of a nagging downtrend that
0
Alliance Data Systems (ADS) Q3 Earnings Preview: How Are Events Shaping Up?
http://www.zacks.com/stock/news/327539/alliance-data-systems-ads-q3-earnings-preview-how-are-events-shaping-up?cid=CS-ZC-FT-327539
Oct 11, 2018 - Alliance Data (ADS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Reversal of fortune for AcelRx Pharma, shares up 26% on potential Ad Com thumbs up for Dsuvia
https://seekingalpha.com/news/3396385-reversal-fortune-acelrx-pharma-shares-26-percent-potential-ad-com-thumbs-dsuvia?source=feed_news_all
Oct 10, 2018 - AcelRx Pharmaceuticals (ACRX +26.4%) is up on a 10x surge in volume on expectations of a positive vote from an FDA advisory committee this Friday related to pain med DSUVIA (sufentanil sublingual tabl
0
Page 1>
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| GRUB | GrubHub Inc. | NYSE | $140.28 | $12.69B |
| AKAM | Akamai Technologies, Inc. | NASDAQ | $74.28 | $12.59B |
| MELI | MercadoLibre, Inc. | NASDAQ | $321.9 | $14.54B |
| CSGP | CoStar Group, Inc. | NASDAQ | $423.29 | $15.4B |
| BR | Broadridge Financial Solutions, Inc. | NYSE | $134.79 | $15.68B |